Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement
Teva Pharmaceutical Industries Ltd. Case Solution And Analysis, HBR Case Study Solution & Analysis of Harvard Case Studies
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Teva Pharmaceutical Industries Limited (TEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile | PDF | Initial Public Offering | Pharmaceutical Industry
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceutical Industries Web Site Editorial Image - Image of mobile, screen: 161664775
TEVA Pharmaceutical Industries Ltd. | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services
Capital Research Global Investors increases ownership in TEVJF / Teva Pharmaceutical Industries Ltd.